Fresenius Medical Care 730 Taylor Ave 8 000 pi² Bureau Immeuble Columbus, OH 43219 2 095 971 $ CAD (262,00 $ CAD/pi²) 7% Taux de capitalisation

Fresenius Medical Care, a publicly traded company, is the world’s leading provider of products and services for patients with chronic kidney disease, established through a merger in 1996. The company operates approximately 3,700 dialysis clinics globally and serves over 299,000 patients per year, supported by around 40 production facilities for dialysis machines, dialyzers, and related supplies. It offers in-center and home dialysis, vascular access care, renal pharmaceuticals, and clinical lab services. In 2025, Fresenius emphasized expanding home dialysis programs and advancing patient-centered technologies. The Morristown, TN center at 420 W Morris Blvd is part of its U.S. network, providing in-center hemodialysis, peritoneal dialysis, and home hemodialysis training. Leadership is based in Germany, but regional leadership, including center operations, is supported by executive and medical officers across North America.